LINC02283

Across TCGA pan-cancer cohorts, LINC02283 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC02283 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02283 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02283 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

MESO, LGG, and BLCA are the cancer types where LINC02283 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.149	0.585	<.001	72	view →
LGG	DFS	Median	All	0.825	0.642	<.001	53	view →
BLCA	OS	Tertile	All	0.216	0.686	.037	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LAML	DFS	Tertile	All	0.028	0.592	<.001	36	view →
READ	OS	Tertile	All	0.183	0.828	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.054	0.780	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	28	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
HNSC	OS	Tertile	IV	0.314	0.651	.018	18	view →
SKCM	OS	Tertile	III,IV	0.232	0.721	.010	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC02283–MESO (OS)

Open the MESO breakdown →